|
ASAP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.062100E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.129800E-02 |
| Normal-vs-Stage2 |
2.214200E-01 |
| Normal-vs-Stage3 |
3.464800E-01 |
| Normal-vs-Stage4 |
6.158000E-01 |
| Stage1-vs-Stage2 |
9.027800E-01 |
| Stage1-vs-Stage3 |
3.866600E-01 |
| Stage1-vs-Stage4 |
3.593200E-01 |
| Stage2-vs-Stage3 |
6.418000E-01 |
| Stage2-vs-Stage4 |
5.514000E-01 |
| Stage3-vs-Stage4 |
8.158800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.723600E-02 |
| Normal-vs-AfricanAmerican |
8.398200E-02 |
| Normal-vs-Asian |
5.267200E-01 |
| Caucasian-vs-AfricanAmerican |
6.707400E-01 |
| Caucasian-vs-Asian |
4.275400E-01 |
| AfricanAmerican-vs-Asian |
3.405000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.359800E-01 |
| Normal-vs-Female |
6.223800E-02 |
| Male-vs-Female |
6.639200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.152000E-02 |
| Normal-vs-Age(41-60Yrs) |
3.342600E-01 |
| Normal-vs-Age(61-80Yrs) |
3.440000E-01 |
| Normal-vs-Age(81-100Yrs) |
2.483600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.306650E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.417400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.488800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.088000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.906600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.161600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.021200E-01 |
| Classical-VS-Follicular |
1.159410E-03 |
| Classical-VS-Other |
2.387800E-02 |
| Classical-VS-Normal |
3.936100E-03 |
| Tall-VS-Follicular |
4.152400E-01 |
| Tall-VS-Other |
7.358000E-02 |
| Tall-VS-Normal |
5.845800E-01 |
| Follicular-VS-Other |
2.059200E-01 |
| Follicular-VS-Normal |
6.569800E-01 |
| Other-VS-Normal |
6.870000E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.466600E-01 |
| Normal-vs-N1 |
3.480200E-01 |
| N0-vs-N1 |
7.570000E-01 |
|
|
